2021
Early Release - Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines - Volume 27, Number 12—December 2021 - Emerging Infectious Diseases journal - CDC
Adams C, Jadi R, Segovia-Chumbez B, Daag J, Ylade M, Medina F, Sharp T, Munoz-Jordan J, Yoon I, Deen J, Lopez A, de Silva A, Premkumar L. Early Release - Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines - Volume 27, Number 12—December 2021 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2021, 27: 3073-3081. PMID: 34808091, PMCID: PMC8632176, DOI: 10.3201/eid2712.211150.Peer-Reviewed Original ResearchConceptsZIKV seroprevalenceDENV transmissionEnvelope domain IIIZika virusSerologic assaysInfectious Diseases journal - CDCType-specific antibodiesDengue virus serotypesYears of agePublic health laboratoriesRelated flavivirusesHealth laboratoriesFlaviviridae familySeroprevalenceChildren 9Virus serotypesDomain IIIVirusAntibodiesAssaysDENVFlaviviruses
2017
Zika Virus -10 Public Health Achievements in 2016 and Future Priorities.
Oussayef N, Pillai S, Honein M, Ben Beard C, Bell B, Boyle C, Eisen L, Kohl K, Kuehnert M, Lathrop E, Martin S, Martin R, McAllister J, McClune E, Mead P, Meaney-Delman D, Petersen B, Petersen L, Polen K, Powers A, Redd S, Sejvar J, Sharp T, Villanueva J, Jamieson D. Zika Virus -10 Public Health Achievements in 2016 and Future Priorities. MMWR Morbidity And Mortality Weekly Report 2017, 65: 1482-1488. PMID: 28056005, DOI: 10.15585/mmwr.mm6552e1.Peer-Reviewed Original ResearchConceptsZika virusPregnant womenZika virus infectionEffective reversible contraceptionPersonal protective practicesPublic health achievementsPublic health activitiesPublic health agenciesPublic health emergencyWorld Health OrganizationSexual transmissionUnintended pregnancyReversible contraceptionVirus infectionCongenital microcephalyEmergency Operations CenterHealth achievementsHealth activitiesHealth agenciesHealth OrganizationHealth emergencyPregnancyVirusProtective practicesWomen